Related Experiment Video
Updated: May 17, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The risk stratification in atrial fibrillation
Domenico Prisco1, Caterina Cenci, Elena Silvestri
1Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy. priscod@aou-careggi.toscana.it
Internal and Emergency Medicine
|October 18, 2012
Summary
Atrial fibrillation (AF) stroke risk stratification models like CHADS(2) have limitations. Newer scores, CHA(2)DS(2)-VASc, and biomarkers improve risk assessment for antithrombotic therapy in AF patients.
Area of Science:
- Cardiology
- Thrombosis Research
- Public Health
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to increased stroke risk.
- Accurate stroke risk stratification is crucial for effective antithrombotic therapy.
- Existing models like CHADS(2) have limitations in identifying all stroke risk factors.
Purpose of the Study:
- To review the evolution and limitations of stroke risk stratification models in AF.
- To highlight newer models and biomarkers for improved thromboembolic risk assessment.
- To emphasize the importance of balancing thromboembolic and bleeding risks.
Main Methods:
- Review of existing stroke risk stratification models for AF.
- Discussion of novel biomarkers and risk factors for ischemic complications.
- Inclusion of bleeding risk assessment tools.
Main Results:
- The CHA(2)DS(2)-VASc score outperforms the CHADS(2) score in predicting stroke risk.
- Biomarkers (e.g., C-reactive protein, interleukin-6) and genetic factors (e.g., Factor II gene polymorphism) are associated with increased risk.
- Chronic kidney disease and AF burden also contribute to stroke risk.
- The HAS-BLED score aids in assessing bleeding risk.
Conclusions:
- Risk stratification in AF requires moving beyond traditional models.
- Integrating novel biomarkers and clinical factors enhances thromboembolic risk assessment.
- Simultaneous evaluation of bleeding risk is essential for personalized antithrombotic strategies.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...